Cohen, 2013, Clinical assessment of Tourette syndrome and tic disorders, Neurosci Biobehav Rev, 37, 997, 10.1016/j.neubiorev.2012.11.013
Hallett, 2015, Tourette Syndrome: update, Brain Dev, 37, 651, 10.1016/j.braindev.2014.11.005
Dale, 2017, Tics and Tourette, Curr Opin Pediatr, 29, 665, 10.1097/MOP.0000000000000546
Ahmed, 2008, Psychogenic and organic movement disorders in children, Dev Med Child Neurol, 50, 300, 10.1111/j.1469-8749.2008.02043.x
Dale, 2010, A prospective study of acute movement disorders in children, Dev Med Child Neurol, 52, 739, 10.1111/j.1469-8749.2009.03598.x
Ganos, 2016, “I swear it is Tourette's!” – On functional coprolalia and other tic-like vocalizations, 1
Association AP, 2013
Robertson, 2009, The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective, J Psychosom Res, 67, 475, 10.1016/j.jpsychores.2009.07.010
Robertson, 2015, A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies, Lancet Psychiatry, 2, 68, 10.1016/S2215-0366(14)00132-1
Marwitz, 2018, Clinical utility of screening for anxiety and depression in children with Tourette Syndrome, J Can Acad Child Adolesc Psychiatry, 27, 15
Eddy, 2013, Altered social cognition in Tourette syndrome: nature and implications, Behav Neurol, 27, 15, 10.1155/2013/417516
Lee, 2017, Tourette Syndrome as an independent risk factor for subsequent sleep disorders in children: a nationwide population-based case-control study, Sleep, 40, 12387, 10.1093/sleep/zsw072
Darrow, 2017, Autism Spectrum Symptoms in a Tourette's Disorder Sample, J Am Acad Child Adolesc Psychiatry, 56, 610, 10.1016/j.jaac.2017.05.002
Eddy, 2011, Clinical correlates of quality of life in Tourette syndrome, Mov Disord, 26, 735, 10.1002/mds.23434
Leckman, 1998, Course of tic severity in Tourette syndrome: the first two decades, Pediatrics, 102, 14, 10.1542/peds.102.1.14
Pappert, 2003, Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome, Neurology, 61, 936, 10.1212/01.WNL.0000086370.10186.7C
Groth, 2017, Course of Tourette Syndrome and comorbidities in a large prospective clinical study, J Am Acad Child Adolesc Psychiatry, 56, 304, 10.1016/j.jaac.2017.01.010
Ganos, 2016, Tics and Tourette's: update on pathophysiology and tic control, Curr OpinNeurol, 29, 513
Qi, 2017, Progress in genetic studies of Tourette's Syndrome, Brain Sci, 7, 133
Singer, 2010, Treatment of Tics and Tourette Syndrome, Curr Treat Options Neurol, 12, 539, 10.1007/s11940-010-0095-4
Verdellen, 2004, Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study, Behav Res Ther, 42, 501, 10.1016/S0005-7967(03)00154-2
Verdellen, 2007, Tic suppression in the treatment of Tourette's syndrome with exposure therapy: the rebound phenomenon reconsidered, Mov Disord, 22, 1601, 10.1002/mds.21577
Seo, 2008, Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder, J Child Adolesc Psychopharmacol, 18, 197, 10.1089/cap.2007.0064
Cho, 2012, A multicenter, randomized, double blind and placebo-controlled study of aripiprazole in children and adolescents with Tourette disorder, Neuropsychiatr Enfance Adolesc, 60, 10.1016/j.neurenf.2012.05.467
Sallee, 2017, Randomized, double blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette's Disorder in children and adolescents, J Child Adolesc Psychopharmacol, 27, 771, 10.1089/cap.2016.0026
Gadow, 2007, Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder, J Am Acad Child Adolesc Psychiatry, 46, 840, 10.1097/chi.0b013e31805c0860
Rizzo, 2013, Tourette Syndrome and comorbid ADHD: current pharmacological treatment options, Eur J Paediatr Neurol, 17, 421, 10.1016/j.ejpn.2013.01.005
Hartmann, 2016, Gilles de la Tourette syndrome–A treatable condition?, Rev Neurol, 172, 1, 10.1016/j.neurol.2016.07.004